Nature Communications (Dec 2020)

Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease

  • Jonas B. Nielsen,
  • Oren Rom,
  • Ida Surakka,
  • Sarah E. Graham,
  • Wei Zhou,
  • Tanmoy Roychowdhury,
  • Lars G. Fritsche,
  • Sarah A. Gagliano Taliun,
  • Carlo Sidore,
  • Yuhao Liu,
  • Maiken E. Gabrielsen,
  • Anne Heidi Skogholt,
  • Brooke Wolford,
  • William Overton,
  • Ying Zhao,
  • Jin Chen,
  • He Zhang,
  • Whitney E. Hornsby,
  • Akua Acheampong,
  • Austen Grooms,
  • Amanda Schaefer,
  • Gregory J. M. Zajac,
  • Luis Villacorta,
  • Jifeng Zhang,
  • Ben Brumpton,
  • Mari Løset,
  • Vivek Rai,
  • Pia R. Lundegaard,
  • Morten S. Olesen,
  • Kent D. Taylor,
  • Nicholette D. Palmer,
  • Yii-Der Chen,
  • Seung H. Choi,
  • Steven A. Lubitz,
  • Patrick T. Ellinor,
  • Kathleen C. Barnes,
  • Michelle Daya,
  • Nicholas Rafaels,
  • Scott T. Weiss,
  • Jessica Lasky-Su,
  • Russell P. Tracy,
  • Ramachandran S. Vasan,
  • L. Adrienne Cupples,
  • Rasika A. Mathias,
  • Lisa R. Yanek,
  • Lewis C. Becker,
  • Patricia A. Peyser,
  • Lawrence F. Bielak,
  • Jennifer A. Smith,
  • Stella Aslibekyan,
  • Bertha A. Hidalgo,
  • Donna K. Arnett,
  • Marguerite R. Irvin,
  • James G. Wilson,
  • Solomon K. Musani,
  • Adolfo Correa,
  • Stephen S. Rich,
  • Xiuqing Guo,
  • Jerome I. Rotter,
  • Barbara A. Konkle,
  • Jill M. Johnsen,
  • Allison E. Ashley-Koch,
  • Marilyn J. Telen,
  • Vivien A. Sheehan,
  • John Blangero,
  • Joanne E. Curran,
  • Juan M. Peralta,
  • Courtney Montgomery,
  • Wayne H-H Sheu,
  • Ren-Hua Chung,
  • Karen Schwander,
  • Seyed M. Nouraie,
  • Victor R. Gordeuk,
  • Yingze Zhang,
  • Charles Kooperberg,
  • Alexander P. Reiner,
  • Rebecca D. Jackson,
  • Eugene R. Bleecker,
  • Deborah A. Meyers,
  • Xingnan Li,
  • Sayantan Das,
  • Ketian Yu,
  • Jonathon LeFaive,
  • Albert Smith,
  • Tom Blackwell,
  • Daniel Taliun,
  • Sebastian Zollner,
  • Lukas Forer,
  • Sebastian Schoenherr,
  • Christian Fuchsberger,
  • Anita Pandit,
  • Matthew Zawistowski,
  • Sachin Kheterpal,
  • Chad M. Brummett,
  • Pradeep Natarajan,
  • David Schlessinger,
  • Seunggeun Lee,
  • Hyun Min Kang,
  • Francesco Cucca,
  • Oddgeir L. Holmen,
  • Bjørn O. Åsvold,
  • Michael Boehnke,
  • Sekar Kathiresan,
  • Goncalo R. Abecasis,
  • Y. Eugene Chen,
  • Cristen J. Willer,
  • Kristian Hveem

DOI
https://doi.org/10.1038/s41467-020-20086-3
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 12

Abstract

Read online

Drugs targeting cardiovascular disease (CVD) can have negative consequences for liver function. Here, the authors combine genome wide analyses on 69,479 individuals to identify loss-of-function variants with beneficial effects on CVD-related traits without negative impacts on liver function.